| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.073 | 0.6 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |